TreeWAS – Variant ID: rs2124379

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
S82.00 Fracture of patella (closed)	0.053	0.947	0.000
S82.0 Fracture of patella	0.041	0.959	0.000
S82.01 Fracture of patella (open)	0.039	0.961	0.000
D86.9 Sarcoidosis, unspecified	0.000	0.966	0.034
D86 Sarcoidosis	0.000	0.968	0.032
D86.0 Sarcoidosis of lung	0.000	0.969	0.031
D86.2 Sarcoidosis of lung with sarcoidosis of lymph nodes	0.000	0.972	0.028
D86.1 Sarcoidosis of lymph nodes	0.000	0.975	0.024
D86.3 Sarcoidosis of skin	0.000	0.976	0.024
D86.8 Sarcoidosis of other and combined sites	0.000	0.978	0.022
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.020	0.980	0.000
T40.2 Other opioids	0.020	0.980	0.000
T40.6 Other and unspecified narcotics	0.019	0.981	0.000
D80-D89 Certain disorders involving the immune mechanism	0.000	0.981	0.019
T36 Poisoning by systemic antibiotics	0.018	0.982	0.000
T36.0 Penicillins	0.018	0.982	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.018	0.982	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.017	0.983	0.000
T40.4 Other synthetic narcotics	0.017	0.983	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.016	0.984	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.016	0.984	0.000
D80 Immunodeficiency with predominantly antibody defects	0.000	0.984	0.016
T36.4 Tetracyclines	0.015	0.984	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.015	0.985	0.000
T40.3 Methadone	0.015	0.985	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.015	0.985	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.015	0.985	0.000
T40.8 Lysergide [LSD]	0.015	0.985	0.000
T40.7 Cannabis (derivatives)	0.015	0.985	0.000
T40.0 Opium	0.015	0.985	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.015	0.985	0.000
D84 Other immunodeficiencies	0.000	0.985	0.015
T40.1 Heroin	0.014	0.985	0.000
N18.3 Chronic kidney disease, stage 3	0.015	0.985	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.015	0.985	0.000
D82 Immunodeficiency associated with other major defects	0.000	0.986	0.014
D83 Common variable immunodeficiency	0.000	0.986	0.014
T36.3 Macrolides	0.014	0.986	0.000
T40.5 Cocaine	0.014	0.986	0.000
D81 Combined immunodeficiencies	0.000	0.986	0.014
D89 Other disorders involving the immune mechanism, not elsewhere classified	0.000	0.986	0.014
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.014	0.986	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.014	0.986	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.013	0.987	0.000
T36.9 Systemic antibiotic, unspecified	0.013	0.987	0.000
T36.8 Other systemic antibiotics	0.013	0.987	0.000
T36.7 Antifungal antibiotics, systemically used	0.013	0.987	0.000
T36.6 Rifamycins	0.013	0.987	0.000
T36.5 Aminoglycosides	0.013	0.987	0.000
T36.2 Chloramphenicol group	0.013	0.987	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.013	0.987	0.000
T47.2 Stimulant laxatives	0.013	0.987	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.013	0.987	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.013	0.987	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.013	0.987	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.013	0.987	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.013	0.987	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.013	0.987	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.013	0.987	0.000
T44.0 Anticholinesterase agents	0.013	0.987	0.000
D80.2 Selective deficiency of immunoglobulin A [IgA]	0.000	0.987	0.013
T46.5 Other antihypertensive drugs, not elsewhere classified	0.012	0.988	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.012	0.988	0.000
T48.5 Anti-common-cold drugs	0.012	0.988	0.000
T47.0 Histamine H(2)-receptor antagonists	0.012	0.988	0.000
T46.1 Calcium-channel blockers	0.012	0.988	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.012	0.988	0.000
D84.9 Immunodeficiency, unspecified	0.000	0.988	0.012
D80.1 Nonfamilial hypogammaglobulinaemia	0.000	0.988	0.012
T50.9 Other and unspecified drugs, medicaments and biological substances	0.012	0.988	0.000
D80.3 Selective deficiency of immunoglobulin G [IgG] subclasses	0.000	0.988	0.012
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.012	0.988	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.012	0.988	0.000
D80.4 Selective deficiency of immunoglobulin M [IgM]	0.000	0.988	0.011
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.011	0.988	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.011	0.988	0.000
T47.7 Emetics	0.011	0.988	0.000
T47.6 Antidiarrhoeal drugs	0.011	0.988	0.000
T47.5 Digestants	0.011	0.988	0.000
T47.4 Other laxatives	0.011	0.988	0.000
T47.3 Saline and osmotic laxatives	0.011	0.988	0.000
D80.8 Other immunodeficiencies with predominantly antibody defects	0.000	0.989	0.011
D80.7 Transient hypogammaglobulinaemia of infancy	0.000	0.989	0.011
D80.6 Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia	0.000	0.989	0.011
D80.5 Immunodeficiency with increased immunoglobulin M [IgM]	0.000	0.989	0.011
D80.0 Hereditary hypogammaglobulinaemia	0.000	0.989	0.011
D89.1 Cryoglobulinaemia	0.000	0.989	0.011
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.011	0.989	0.000
D89.2 Hypergammaglobulinaemia, unspecified	0.000	0.989	0.011
T50.6 Antidotes and chelating agents, not elsewhere classified	0.011	0.989	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.011	0.989	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.011	0.989	0.000
T46.7 Peripheral vasodilators	0.011	0.989	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.011	0.989	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.011	0.989	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.011	0.989	0.000
T48.4 Expectorants	0.011	0.989	0.000
T48.3 Antitussives	0.011	0.989	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.011	0.989	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.011	0.989	0.000
T48.0 Oxytocic drugs	0.011	0.989	0.000
D82.1 Di George's syndrome	0.000	0.989	0.011
T37.8 Other specified systemic anti-infectives and antiparasitics	0.011	0.989	0.000
D84.8 Other specified immunodeficiencies	0.000	0.989	0.011
D84.0 Lymphocyte function antigen-1 [LFA-1] defect	0.000	0.989	0.011
T50.7 Analeptics and opioid receptor antagonists	0.011	0.989	0.000
T50.5 Appetite depressants	0.011	0.989	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.011	0.989	0.000
T50.1 Loop [high-ceiling] diuretics	0.011	0.989	0.000
T50.0 Mineralocorticoids and their antagonists	0.011	0.989	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.011	0.989	0.000
D83.9 Common variable immunodeficiency, unspecified	0.000	0.989	0.010
D82.9 Immunodeficiency associated with major defect, unspecified	0.000	0.989	0.010
D82.8 Immunodeficiency associated with other specified major defects	0.000	0.989	0.010
D82.4 Hyperimmunoglobulin E [IgE] syndrome	0.000	0.989	0.010
D82.3 Immunodeficiency following hereditary defective response to Epstein-Barr virus	0.000	0.989	0.010
D82.2 Immunodeficiency with short-limbed stature	0.000	0.989	0.010
D82.0 Wiskott-Aldrich syndrome	0.000	0.989	0.010
D80.9 Immunodeficiency with predominantly antibody defects, unspecified	0.000	0.990	0.010
D83.8 Other common variable immunodeficiencies	0.000	0.990	0.010
D83.2 Common variable immunodeficiency with autoantibodies to B- or T-cells	0.000	0.990	0.010
D83.1 Common variable immunodeficiency with predominant immunoregulatory T-cell disorders	0.000	0.990	0.010
D83.0 Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function	0.000	0.990	0.010
T50.8 Diagnostic agents	0.010	0.990	0.000
D81.9 Combined immunodeficiency, unspecified	0.000	0.990	0.010
D81.8 Other combined immunodeficiencies	0.000	0.990	0.010
D81.7 Major histocompatibility complex class II deficiency	0.000	0.990	0.010
D81.6 Major histocompatibility complex class I deficiency	0.000	0.990	0.010
D81.5 Purine nucleoside phosphorylase [PNP] deficiency	0.000	0.990	0.010
D81.4 Nezelof's syndrome	0.000	0.990	0.010
D81.3 Adenosine deaminase [ADA] deficiency	0.000	0.990	0.010
D81.2 Severe combined immunodeficiency [SCID] with low or normal B-cell numbers	0.000	0.990	0.010
D81.1 Severe combined immunodeficiency [SCID] with low T- and B-cell numbers	0.000	0.990	0.010
D81.0 Severe combined immunodeficiency [SCID] with reticular dysgenesis	0.000	0.990	0.010
D89.8 Other specified disorders involving the immune mechanism, not elsewhere classified	0.000	0.990	0.010
D89.3 Immune reconstitution syndrome	0.000	0.990	0.010
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.010	0.990	0.000
T37.5 Antiviral drugs	0.010	0.990	0.000
T37.4 Anthelminthics	0.010	0.990	0.000
T37.3 Other antiprotozoal drugs	0.010	0.990	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.010	0.990	0.000
T37.1 Antimycobacterial drugs	0.010	0.990	0.000
T37.0 Sulphonamides	0.010	0.990	0.000
L57.0 Actinic keratosis	0.010	0.990	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.010	0.990	0.000
D84.1 Defects in the complement system	0.000	0.990	0.010
T50.4 Drugs affecting uric acid metabolism	0.010	0.990	0.000
D89.0 Polyclonal hypergammaglobulinaemia	0.000	0.990	0.010
T41.5 Therapeutic gases	0.009	0.991	0.000
T41.4 Anaesthetic, unspecified	0.009	0.991	0.000
T41.3 Local anaesthetics	0.009	0.991	0.000
T41.2 Other and unspecified general anaesthetics	0.009	0.991	0.000
T41.1 Intravenous anaesthetics	0.009	0.991	0.000
T41.0 Inhaled anaesthetics	0.009	0.991	0.000
T49.9 Topical agent, unspecified	0.009	0.991	0.000
T49.8 Other topical agents	0.009	0.991	0.000
T49.7 Dental drugs, topically applied	0.009	0.991	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.009	0.991	0.000
T49.5 Ophthalmological drugs and preparations	0.009	0.991	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.009	0.991	0.000
T49.3 Emollients, demulcents and protectants	0.009	0.991	0.000
T49.2 Local astringents and local detergents	0.009	0.991	0.000
T49.1 Antipruritics	0.009	0.991	0.000
T38.5 Other oestrogens and progestogens	0.009	0.991	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.008	0.991	0.000
T38.0 Glucocorticoids and synthetic analogues	0.008	0.992	0.000
K04.6 Periapical abscess with sinus	0.000	0.992	0.008
T38.9 Other and unspecified hormone antagonists	0.008	0.992	0.000
T38.7 Androgens and anabolic congeners	0.008	0.992	0.000
T38.4 Oral contraceptives	0.008	0.992	0.000
T38.2 Antithyroid drugs	0.008	0.992	0.000
F20.9 Schizophrenia, unspecified	0.008	0.992	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.008	0.992	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.008	0.992	0.000
O47.1 False labour at or after 37 completed weeks of gestation	0.000	0.992	0.008
T38.1 Thyroid hormones and substitutes	0.008	0.992	0.000
O47.0 False labour before 37 completed weeks of gestation	0.000	0.992	0.008
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.008	0.992	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.007	0.993	0.000
D89.9 Disorder involving the immune mechanism, unspecified	0.000	0.993	0.007
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.007	0.993	0.000
O47 False labour	0.000	0.993	0.007
T42.1 Iminostilbenes	0.006	0.994	0.000
T42.3 Barbiturates	0.006	0.994	0.000
C34.2 Middle lobe, bronchus or lung	0.006	0.994	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.006	0.994	0.000
C34.9 Bronchus or lung, unspecified	0.006	0.994	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.006	0.994	0.000
T42.2 Succinimides and oxazolidinediones	0.006	0.994	0.000
F01.9 Vascular dementia, unspecified	0.000	0.994	0.006
T45.9 Primarily systemic and haematological agent, unspecified	0.005	0.994	0.000
T45.8 Other primarily systemic and haematological agents	0.005	0.994	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.005	0.994	0.000
T45.6 Fibrinolysis-affecting drugs	0.005	0.994	0.000
T45.4 Iron and its compounds	0.005	0.994	0.000
T45.3 Enzymes, not elsewhere classified	0.005	0.994	0.000
I27.2 Other secondary pulmonary hypertension	0.000	0.995	0.005
T45.0 Antiallergic and antiemetic drugs	0.005	0.995	0.000
O47.9 False labour, unspecified	0.000	0.995	0.005
C34 Malignant neoplasm of bronchus and lung	0.005	0.995	0.000
Z95.2 Presence of prosthetic heart valve	0.005	0.995	0.000
S27.00 Traumatic pneumothorax (without open wound into thoracic cavity)	0.005	0.995	0.000
T45.2 Vitamins, not elsewhere classified	0.005	0.995	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.005	0.995	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.005	0.995	0.000
T42.0 Hydantoin derivatives	0.004	0.995	0.000
T45.5 Anticoagulants	0.004	0.995	0.000
B96.3 Haemophilus influenzae [H. influenzae] as the cause of diseases classified to other chapters	0.004	0.996	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.004	0.996	0.000
G72.0 Drug-induced myopathy	0.004	0.996	0.000
C34.8 Overlapping lesion of bronchus and lung	0.004	0.996	0.000
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs	0.004	0.996	0.000
T91.3 Sequelae of injury of spinal cord	0.004	0.996	0.000
G72.9 Myopathy, unspecified	0.004	0.996	0.000
Q50.4 Embryonic cyst of Fallopian tube	0.004	0.996	0.000
T91 Sequelae of injuries of neck and trunk	0.004	0.996	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.004	0.996	0.000
C32.0 Glottis	0.004	0.996	0.000
C38 Malignant neoplasm of heart, mediastinum and pleura	0.004	0.996	0.000
T91.9 Sequelae of unspecified injury of neck and trunk	0.004	0.996	0.000
C34.0 Main bronchus	0.004	0.996	0.000
F20 Schizophrenia	0.004	0.996	0.000
T91.8 Sequelae of other specified injuries of neck and trunk	0.004	0.996	0.000
C32 Malignant neoplasm of larynx	0.004	0.996	0.000
T39.4 Antirheumatics, not elsewhere classified	0.003	0.996	0.000
T39.2 Pyrazolone derivatives	0.003	0.996	0.000
T91.2 Sequelae of other fracture of thorax and pelvis	0.004	0.996	0.000
G72 Other myopathies	0.003	0.997	0.000
C38.3 Mediastinum, part unspecified	0.003	0.997	0.000
C37 Malignant neoplasm of thymus	0.003	0.997	0.000
C80.9 Malignant neoplasm, unspecified	0.000	0.997	0.003
I27 Other pulmonary heart diseases	0.000	0.997	0.003
T91.1 Sequelae of fracture of spine	0.003	0.997	0.000
C33 Malignant neoplasm of trachea	0.003	0.997	0.000
C31 Malignant neoplasm of accessory sinuses	0.003	0.997	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.003	0.997	0.000
J35.0 Chronic tonsillitis	0.000	0.997	0.003
C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs	0.003	0.997	0.000
F20.8 Other schizophrenia	0.003	0.997	0.000
I27.8 Other specified pulmonary heart diseases	0.000	0.997	0.003
G57.8 Other mononeuropathies of lower limb	0.000	0.997	0.003
C38.4 Pleura	0.003	0.997	0.000
T91.5 Sequelae of injury of intra-abdominal and pelvic organs	0.003	0.997	0.000
T91.4 Sequelae of injury of intrathoracic organs	0.003	0.997	0.000
T91.0 Sequelae of superficial injury and open wound of neck and trunk	0.003	0.997	0.000
C30 Malignant neoplasm of nasal cavity and middle ear	0.003	0.997	0.000
O81.4 Vacuum extractor delivery	0.003	0.997	0.000
C38.8 Overlapping lesion of heart, mediastinum and pleura	0.003	0.997	0.000
C38.2 Posterior mediastinum	0.003	0.997	0.000
C38.1 Anterior mediastinum	0.003	0.997	0.000
C38.0 Heart	0.003	0.997	0.000
F20.6 Simple schizophrenia	0.003	0.997	0.000
F20.4 Postschizophrenic depression	0.003	0.997	0.000
F20.3 Undifferentiated schizophrenia	0.003	0.997	0.000
F20.1 Hebephrenic schizophrenia	0.003	0.997	0.000
C32.8 Overlapping lesion of larynx	0.003	0.997	0.000
C32.3 Laryngeal cartilage	0.003	0.997	0.000
C32.2 Subglottis	0.003	0.997	0.000
H92.1 Otorrhoea	0.000	0.997	0.003
I27.9 Pulmonary heart disease, unspecified	0.000	0.997	0.003
C31.0 Maxillary sinus	0.003	0.997	0.000
F20.2 Catatonic schizophrenia	0.003	0.997	0.000
G72.8 Other specified myopathies	0.003	0.997	0.000
G72.3 Periodic paralysis	0.003	0.997	0.000
G72.2 Myopathy due to other toxic agents	0.003	0.997	0.000
T88.7 Unspecified adverse effect of drug or medicament	0.003	0.997	0.000
C32.9 Larynx, unspecified	0.003	0.997	0.000
C34.1 Upper lobe, bronchus or lung	0.003	0.997	0.000
G72.1 Alcoholic myopathy	0.003	0.997	0.000
I27.1 Kyphoscoliotic heart disease	0.000	0.997	0.003
N28.9 Disorder of kidney and ureter, unspecified	0.003	0.997	0.000
S27.0 Traumatic pneumothorax	0.003	0.997	0.000
C31.9 Accessory sinus, unspecified	0.002	0.997	0.000
C31.8 Overlapping lesion of accessory sinuses	0.002	0.997	0.000
C31.3 Sphenoidal sinus	0.002	0.997	0.000
C31.2 Frontal sinus	0.002	0.997	0.000
C31.1 Ethmoidal sinus	0.002	0.997	0.000
J35.1 Hypertrophy of tonsils	0.000	0.997	0.003
J94.8 Other specified pleural conditions	0.000	0.997	0.003
K31.7 Polyp of stomach and duodenum	0.003	0.997	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.003	0.997	0.000
G72.4 Inflammatory myopathy, not elsewhere classified	0.002	0.997	0.000
I71.9 Aortic aneurysm of unspecified site, without mention of rupture	0.000	0.997	0.003
C39.9 Ill-defined sites within the respiratory system	0.002	0.997	0.000
C39.8 Overlapping lesion of respiratory and intrathoracic organs	0.002	0.997	0.000
C39.0 Upper respiratory tract, part unspecified	0.002	0.997	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.003	0.997	0.000
O62.2 Other uterine inertia	0.000	0.997	0.002
F20.5 Residual schizophrenia	0.002	0.998	0.000
T88.4 Failed or difficult intubation	0.002	0.998	0.000
M89.0 Algoneurodystrophy	0.002	0.998	0.000
C30.1 Middle ear	0.002	0.998	0.000
F20.0 Paranoid schizophrenia	0.002	0.998	0.000
T88 Other complications of surgical and medical care, not elsewhere classified	0.002	0.998	0.000
T39.1 4-Aminophenol derivatives	0.002	0.998	0.000
M89.09 Algoneurodystrophy (Site unspecified)	0.002	0.998	0.000
M89.04 Algoneurodystrophy (Hand)	0.002	0.998	0.000
I27.0 Primary pulmonary hypertension	0.000	0.998	0.002
M40.24 Other and unspecified kyphosis (Thoracic region)	0.002	0.998	0.000
D35.1 Parathyroid gland	0.002	0.998	0.000
M89.07 Algoneurodystrophy (Ankle and foot)	0.002	0.998	0.000
M89.03 Algoneurodystrophy (Forearm)	0.002	0.998	0.000
T88.6 Anaphylactic shock due to adverse effect of correct drug or medicament properly administered	0.002	0.998	0.000
F01 Vascular dementia	0.000	0.998	0.002
J35 Chronic diseases of tonsils and adenoids	0.000	0.998	0.002
O75.8 Other specified complications of labour and delivery	0.000	0.998	0.002
S02.80 Fractures of other skull and facial bones (closed)	0.002	0.998	0.000
C30.0 Nasal cavity	0.002	0.998	0.000
Q50 Congenital malformations of ovaries, Fallopian tubes and broad ligaments	0.002	0.998	0.000
M89.01 Algoneurodystrophy (Shoulder region)	0.002	0.998	0.000
C32.1 Supraglottis	0.002	0.998	0.000
L20.9 Atopic dermatitis, unspecified	0.000	0.998	0.002
N08.3 Glomerular disorders in diabetes mellitus	0.002	0.998	0.000
M40.2 Other and unspecified kyphosis	0.002	0.998	0.000
S27.01 Traumatic pneumothorax (with open wound into thoracic cavity)	0.002	0.998	0.000
T88.9 Complication of surgical and medical care, unspecified	0.002	0.998	0.000
M40.26 Other and unspecified kyphosis (Lumbar region)	0.002	0.998	0.000
I63.8 Other cerebral infarction	0.000	0.998	0.002
T88.5 Other complications of anaesthesia	0.002	0.998	0.000
Z90.3 Acquired absence of part of stomach	0.002	0.998	0.000
M40.22 Other and unspecified kyphosis (Cervical region)	0.002	0.998	0.000
C78.5 Secondary malignant neoplasm of large intestine and rectum	0.000	0.998	0.002
M89.08 Algoneurodystrophy (Other)	0.002	0.998	0.000
M89.05 Algoneurodystrophy (Pelvic region and thigh)	0.002	0.998	0.000
M89.02 Algoneurodystrophy (Upper arm)	0.002	0.998	0.000
Q50.0 Congenital absence of ovary	0.002	0.998	0.000
S32.70 Multiple fractures of lumbar spine and pelvis (closed)	0.002	0.998	0.000
M89.00 Algoneurodystrophy (Multiple sites)	0.002	0.998	0.000
T88.3 Malignant hyperthermia due to anaesthesis	0.002	0.998	0.000
T88.1 Other complications following immunisation, not elsewhere classified	0.002	0.998	0.000
T88.0 Infection following immunisation	0.002	0.998	0.000
Z39.1 Care and examination of lactating mother	0.000	0.998	0.002
S06.80 Other intracranial injuries (without open intracranial wound)	0.002	0.998	0.000
H92.0 Otalgia	0.000	0.998	0.002
J35.8 Other chronic diseases of tonsils and adenoids	0.000	0.998	0.002
M40.29 Other and unspecified kyphosis (Site unspecified)	0.002	0.998	0.000
T88.8 Other specified complications of surgical and medical care, not elsewhere classified	0.002	0.998	0.000
F01.8 Other vascular dementia	0.000	0.998	0.002
F01.3 Mixed cortical and subcortical vascular dementia	0.000	0.998	0.002
F01.2 Subcortical vascular dementia	0.000	0.998	0.002
F01.0 Vascular dementia of acute onset	0.000	0.998	0.002
L57 Skin changes due to chronic exposure to nonionising radiation	0.002	0.998	0.000
J35.3 Hypertrophy of tonsils with hypertrophy of adenoids	0.000	0.998	0.002
J35.2 Hypertrophy of adenoids	0.000	0.998	0.002
Y57.9 Drug or medicament, unspecified	0.002	0.998	0.000
M89.06 Algoneurodystrophy (Lower leg)	0.002	0.998	0.000
D22.0 Melanocytic naevi of lip	0.000	0.998	0.002
T88.2 Shock due to anaesthesia	0.002	0.998	0.000
R72 Abnormality of white blood cells, not elsewhere classified	0.002	0.998	0.000
Q50.6 Other congenital malformatons of Fallopian tube and broad ligament	0.002	0.998	0.000
Q50.3 Other congenital malformations of ovary	0.002	0.998	0.000
Q50.2 Congenital torsion of ovary	0.002	0.998	0.000
Q50.1 Developmental ovarian cyst	0.002	0.998	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
M22.4 Chondromalacia patellae	0.000	0.998	0.002
M40.28 Other and unspecified kyphosis (Sacral and sacrococcygeal region)	0.002	0.998	0.000
M40.27 Other and unspecified kyphosis (Lumbosacral region)	0.002	0.998	0.000
M40.25 Other and unspecified kyphosis (Thoracolumbar region)	0.002	0.998	0.000
M40.23 Other and unspecified kyphosis (Cervicothoracic region)	0.002	0.998	0.000
M40.21 Other and unspecified kyphosis (Occipito-atlanto-axial region)	0.002	0.998	0.000
M40.20 Other and unspecified kyphosis (Multiple sites in spine)	0.002	0.998	0.000
N18.4 Chronic kidney disease, stage 4	0.002	0.998	0.000
S89.9 Unspecified injury of lower leg	0.000	0.998	0.002
R30.9 Painful micturition, unspecified	0.002	0.998	0.000
H92 Otalgia and effusion of ear	0.000	0.998	0.002
F01.1 Multi-infarct dementia	0.000	0.998	0.002
N18 Chronic renal failure	0.002	0.998	0.000
R76.8 Other specified abnormal immunological findings in serum	0.002	0.998	0.000
K04.5 Chronic apical periodontitis	0.002	0.998	0.000
Q50.5 Embryonic cyst of broad ligament	0.002	0.998	0.000
N08 Glomerular disorders in diseases classified elsewhere	0.002	0.998	0.000
S12.70 Multiple fractures of cervical spine (closed)	0.000	0.998	0.002
L57.5 Actinic granuloma	0.001	0.998	0.000
N18.1 Chronic kidney disease, stage 1	0.002	0.998	0.000
T43.6 Psychostimulants with abuse potential	0.002	0.998	0.000
S32.30 Fracture of ilium (closed)	0.002	0.998	0.000
L57.3 Poikiloderma of Civatte	0.001	0.998	0.000
L57.2 Cutis rhomboidalis nuchae	0.001	0.998	0.000
L57.1 Actinic reticuloid	0.001	0.998	0.000
M89.8 Other specified disorders of bone	0.002	0.998	0.000
M89.87 Other specified disorders of bone (Ankle and foot)	0.002	0.998	0.000
J35.9 Chronic disease of tonsils and adenoids, unspecified	0.000	0.998	0.002
N08.5 Glomerular disorders in systemic connective tissue disorders	0.002	0.998	0.000
H17.9 Corneal scar and opacity, unspecified	0.000	0.998	0.002
R57.2 Septic shock	0.000	0.998	0.002
M89 Other disorders of bone	0.002	0.998	0.000
A41.8 Other specified septicaemia	0.000	0.998	0.002
Q07.0 Arnold-Chiari syndrome	0.002	0.998	0.000
T43.9 Psychotropic drug, unspecified	0.001	0.998	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.001	0.998	0.000
U88 Agent resistant to multiple antibiotics	0.002	0.998	0.000
M87.20 Osteonecrosis due to previous trauma (Multiple sites)	0.002	0.998	0.000
N08.4 Glomerular disorders in other endocrine, nutritional and metabolic diseases	0.001	0.998	0.000
N18.8 Other chronic renal failure	0.002	0.998	0.000
M90.84 Osteopathy in other diseases classified elsewhere (Hand)	0.001	0.998	0.000
C34.3 Lower lobe, bronchus or lung	0.002	0.998	0.000
M89.88 Other specified disorders of bone (Other)	0.001	0.998	0.000
S72.40 Fracture of lower end of femur (closed)	0.000	0.998	0.002
N04.0 Minor glomerular abnormality	0.001	0.998	0.000
S32.7 Multiple fractures of lumbar spine and pelvis	0.001	0.998	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.001	0.998	0.000
H18.5 Hereditary corneal dystrophies	0.002	0.998	0.000
H18.1 Bullous keratopathy	0.001	0.998	0.000
N04.9 Unspecified	0.001	0.998	0.000
N08.8 Glomerular disorders in other diseases classified elsewhere	0.001	0.998	0.000
N08.2 Glomerular disorders in blood diseases and disorders involving the immune mechanism	0.001	0.998	0.000
N08.1 Glomerular disorders in neoplastic diseases	0.001	0.998	0.000
N08.0 Glomerular disorders in infectious and parasitic diseases classified elsewhere	0.001	0.998	0.000
H10.9 Conjunctivitis, unspecified	0.000	0.998	0.001
M16.3 Other dysplastic coxarthrosis	0.001	0.998	0.000
L57.9 Skin changes due to chronic exposure to nonionising radiation, unspecified	0.001	0.999	0.000
M93.9 Osteochondropathy, unspecified	0.000	0.999	0.001
T39.0 Salicylates	0.001	0.999	0.000
M89.89 Other specified disorders of bone (Site unspecified)	0.001	0.999	0.000
M89.84 Other specified disorders of bone (Hand)	0.001	0.999	0.000
M89.82 Other specified disorders of bone (Upper arm)	0.001	0.999	0.000
M89.81 Other specified disorders of bone (Shoulder region)	0.001	0.999	0.000
M89.80 Other specified disorders of bone (Multiple sites)	0.001	0.999	0.000
G80.9 Infantile cerebral palsy, unspecified	0.000	0.999	0.001
H92.2 Otorrhagia	0.000	0.999	0.001
M89.83 Other specified disorders of bone (Forearm)	0.001	0.999	0.000
M90.80 Osteopathy in other diseases classified elsewhere (Multiple sites)	0.001	0.999	0.000
K25.3 Acute without haemorrhage or perforation	0.000	0.999	0.001
L81.4 Other melanin hyperpigmentation	0.000	0.999	0.001
M89.6 Osteopathy after poliomyelitis	0.001	0.999	0.000
M89.2 Other disorders of bone development and growth	0.001	0.999	0.000
M89.1 Epiphyseal arrest	0.001	0.999	0.000
S12.7 Multiple fractures of cervical spine	0.000	0.999	0.001
M89.4 Other hypertrophic osteo-arthropathy	0.001	0.999	0.000
M90.8 Osteopathy in other diseases classified elsewhere	0.001	0.999	0.000
N04 Nephrotic syndrome	0.001	0.999	0.000
M23.61 Other spontaneous disruption of ligament(s) of knee (Anterior cruciate ligament or Anterior horn of medial meniscus)	0.000	0.999	0.001
L57.4 Cutis laxa senilis	0.001	0.999	0.000
N83.3 Acquired atrophy of ovary and Fallopian tube	0.000	0.999	0.001
T43.5 Other and unspecified antipsychotics and neuroleptics	0.001	0.999	0.000
M89.38 Hypertrophy of bone (Other)	0.001	0.999	0.000
M89.86 Other specified disorders of bone (Lower leg)	0.001	0.999	0.000
M89.85 Other specified disorders of bone (Pelvic region and thigh)	0.001	0.999	0.000
M89.5 Osteolysis	0.001	0.999	0.000
M89.3 Hypertrophy of bone	0.001	0.999	0.000
S14.1 Other and unspecified injuries of cervical spinal cord	0.000	0.999	0.001
M23.80 Other internal derangements of knee (Multiple sites)	0.000	0.999	0.001
S32.71 Multiple fractures of lumbar spine and pelvis (open)	0.001	0.999	0.000
G71.1 Myotonic disorders	0.001	0.999	0.000
S32.3 Fracture of ilium	0.001	0.999	0.000
T42.4 Benzodiazepines	0.001	0.999	0.000
H02.3 Blepharochalasis	0.000	0.999	0.001
N04.2 Diffuse membranous glomerulonephritis	0.001	0.999	0.000
N18.2 Chronic kidney disease, stage 2	0.001	0.999	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.001	0.999	0.000
Y44.2 Anticoagulants	0.000	0.999	0.001
G70-G73 Diseases of myoneural junction and muscle	0.001	0.999	0.000
S12.90 Fracture of neck, part unspecified (closed)	0.000	0.999	0.001
S32.50 Fracture of pubis (closed)	0.001	0.999	0.000
I85.0 Oesophageal varices with bleeding	0.000	0.999	0.001
S02.8 Fractures of other skull and facial bones	0.001	0.999	0.000
M79.70 Fibromyalgia (Multiple sites)	0.000	0.999	0.001
M89.19 Epiphyseal arrest (Site unspecified)	0.001	0.999	0.000
M89.18 Epiphyseal arrest (Other)	0.001	0.999	0.000
M89.17 Epiphyseal arrest (Ankle and foot)	0.001	0.999	0.000
M89.16 Epiphyseal arrest (Lower leg)	0.001	0.999	0.000
M89.15 Epiphyseal arrest (Pelvic region and thigh)	0.001	0.999	0.000
M89.14 Epiphyseal arrest (Hand)	0.001	0.999	0.000
M89.13 Epiphyseal arrest (Forearm)	0.001	0.999	0.000
M89.12 Epiphyseal arrest (Upper arm)	0.001	0.999	0.000
M89.11 Epiphyseal arrest (Shoulder region)	0.001	0.999	0.000
M89.10 Epiphyseal arrest (Multiple sites)	0.001	0.999	0.000
M89.29 Other disorders of bone development and growth (Site unspecified)	0.001	0.999	0.000
M89.28 Other disorders of bone development and growth (Other)	0.001	0.999	0.000
M89.27 Other disorders of bone development and growth (Ankle and foot)	0.001	0.999	0.000
M89.26 Other disorders of bone development and growth (Lower leg)	0.001	0.999	0.000
M89.25 Other disorders of bone development and growth (Pelvic region and thigh)	0.001	0.999	0.000
M89.24 Other disorders of bone development and growth (Hand)	0.001	0.999	0.000
M89.23 Other disorders of bone development and growth (Forearm)	0.001	0.999	0.000
M89.22 Other disorders of bone development and growth (Upper arm)	0.001	0.999	0.000
M89.21 Other disorders of bone development and growth (Shoulder region)	0.001	0.999	0.000
M89.20 Other disorders of bone development and growth (Multiple sites)	0.001	0.999	0.000
M89.69 Osteopathy after poliomyelitis (Site unspecified)	0.001	0.999	0.000
M89.68 Osteopathy after poliomyelitis (Other)	0.001	0.999	0.000
M89.67 Osteopathy after poliomyelitis (Ankle and foot)	0.001	0.999	0.000
M89.66 Osteopathy after poliomyelitis (Lower leg)	0.001	0.999	0.000
M89.65 Osteopathy after poliomyelitis (Pelvic region and thigh)	0.001	0.999	0.000
M89.64 Osteopathy after poliomyelitis (Hand)	0.001	0.999	0.000
M89.63 Osteopathy after poliomyelitis (Forearm)	0.001	0.999	0.000
M89.62 Osteopathy after poliomyelitis (Upper arm)	0.001	0.999	0.000
M89.61 Osteopathy after poliomyelitis (Shoulder region)	0.001	0.999	0.000
M89.60 Osteopathy after poliomyelitis (Multiple sites)	0.001	0.999	0.000
S12.71 Multiple fractures of cervical spine (open)	0.000	0.999	0.001
F22.0 Delusional disorder	0.001	0.999	0.000
N04.8 Other	0.001	0.999	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.000	0.999	0.001
M89.49 Other hypertrophic osteoarthropathy (Site unspecified)	0.001	0.999	0.000
M89.48 Other hypertrophic osteoarthropathy (Other)	0.001	0.999	0.000
M89.47 Other hypertrophic osteoarthropathy (Ankle and foot)	0.001	0.999	0.000
M89.46 Other hypertrophic osteoarthropathy (Lower leg)	0.001	0.999	0.000
M89.45 Other hypertrophic osteoarthropathy (Pelvic region and thigh)	0.001	0.999	0.000
M89.44 Other hypertrophic osteoarthropathy (Hand)	0.001	0.999	0.000
M89.43 Other hypertrophic osteoarthropathy (Forearm)	0.001	0.999	0.000
M89.42 Other hypertrophic osteoarthropathy (Upper arm)	0.001	0.999	0.000
M89.41 Other hypertrophic osteoarthropathy (Shoulder region)	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations